Product Name
|
Ciprofloxacin hydrochloride
|
Synonyms
|
Ciprofloxacin hcl monohydrate; 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid hydrochloride monohydrate; Ciprofloxacin Monohydrochloridecas monohydrate; Ciprofloxacin hydrochloride monohydrate; 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid, monohydrochloride, monohydrate; 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride hydrate
|
CAS
|
86393-32-0
|
Molecular formula
|
C17H21ClFN3O4
|
Molecular Weight
|
385.82
|
Molecular Structure
|
|
Physical and Chemical Properties
|
|
General Description
|
White or yellowish crystalline powder
|
Usage
|
Broad-spectrum antibacterial drugs are suitable for remixed infection, mainly for chronic respiratory tract, e. coli, infectious rhinitis, avian cholera, avian typhoid, etc.
|
Packing
|
25kg/Drum or customized requirement packing
|
Specifications
|
Items
|
Standard
|
Appearance
|
White or yellowish crystalline powder
|
Identification
|
A.H-NMR:Comply with the structure |
B.LC-MS:Comply with the structure |
C.The IR spectrum of sample should be identical with that of reference standard; |
D.HPLC-ESI-MSThe retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay. |
Crystallinity
|
meets the requirements.
|
Loss on drying
|
≤2.0%
|
Heavy metals
|
≤10 ppm
|
Water
|
≤1.0%
|
Sulphated ash
|
≤0.5%, determined on 1.0 g.
|
Related substances
|
Unspecified impurities: for each impurity
|
≤0.10%
|
Total Impurity
|
≤0.5%
|
Purity
|
≥99.0%
|
Assay
|
99.0%~101.0% (anhydrous substance).
|
Microbiological Analysis |
Total plate count
|
≤1000cfu/g
|
Yeast and Moulds
|
≤100cfu/g
|
E. Coli.
|
Absent
|
Salmonella
|
Absent
|
S.aureus
|
Absent
|
Storage
|
Preserve in well-closed, light-resistant and airtight containers.
|